<DOC>
	<DOC>NCT00990223</DOC>
	<brief_summary>To evaluate the changes in serum aldosterone and plasma renin activity on Day 0 and on Days 1 and 10 after administration of 100 mg of eplerenone daily for 10 days.</brief_summary>
	<brief_title>Effects Of Eplerenone On Serum Aldesterone And Plasma Renin Activity</brief_title>
	<detailed_description />
	<mesh_term>Eplerenone</mesh_term>
	<mesh_term>Spironolactone</mesh_term>
	<criteria>Body Mass Index (BMI) of 17.5 to 30.5 kg/m2; and a total body weight &gt;50 kg (110 lbs) Subjects who are willing and able to comply with scheduled visits, treatment plan, laboratory tests, and other study procedures. Evidence or history of clinically significant disease Subjects with a supine BP greater than or equal to 140 mm Hg systolic or greater than or equal to 90 mm Hg diastolic or &lt;100 mm Hg systolic and &lt;60 mm Hg diastolic on a single measurement, as described in the protocol Blood donation of approximately 1 pint (500 mL) within 56 days prior to dosing History of sensitivity to eplerenone, spironolactone or related compounds. Serum potassium &gt;5.0 mEq/L at screening or Day 0</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2011</verification_date>
	<keyword>Eplerenone Aldosterone and Plasma Renin Activity responses Pharmacodynamics</keyword>
</DOC>